CryoLife, Inc. (CRY): Price and Financial Metrics

CryoLife, Inc. (CRY): $17.88

0.25 (+1.42%)

POWR Rating

Component Grades








CRY Price/Volume Stats

Current price $17.88 52-week high $32.34
Prev. close $17.63 52-week low $16.95
Day low $17.49 Volume 257,400
Day high $18.22 Avg. volume 198,221
50-day MA $19.29 Dividend yield N/A
200-day MA $24.09 Market Cap 703.22M

CRY Stock Price Chart Interactive Chart >

CryoLife, Inc. (CRY) Company Bio

CryoLife Inc. engages in the manufacturing, processing, and distribution of implantable living tissues and medical devices used in cardiac and vascular surgical procedures. The company was founded in 1984 and is based in Kennesaw, Georgia.

CRY Latest News Stream

Event/Time News Detail
Loading, please wait...

CRY Latest Social Stream

Loading social stream, please wait...

View Full CRY Social Stream

Latest CRY News From Around the Web

Below are the latest news stories about Cryolife Inc that investors may wish to consider to help them evaluate CRY as an investment opportunity.

CryoLife Announces Corporate Rebranding and Changes Name to Artivion

CryoLife, Inc. (NYSE: CRY), a leading cardiac and vascular surgery company focused on aortic disease, announced today that it was renaming and rebranding itself to Artivion, Inc., effective immediately. Derived from the words "aorta", "innovation", and "vision", the company's new name and brand reflect its evolution to focus on providing innovative technologies to surgeons who treat patients with aortic disease. In conjunction with these changes, effective January 24, 2022, the company will also

Yahoo | January 18, 2022

CryoLife (CRY) Investor Presentation (Slideshow)

The following slide deck was published by CryoLife, Inc. in conjunction with this event....

SA Transcripts on Seeking Alpha | January 14, 2022

Are CryoLife, Inc.'s (NYSE:CRY) Mixed Financials Driving The Negative Sentiment?

It is hard to get excited after looking at CryoLife's (NYSE:CRY) recent performance, when its stock has declined 13...

Yahoo | December 27, 2021

CryoLife to Participate in the Canaccord Genuity Virtual MedTech, Diagnostics, and Digital Health & Services Forum

CryoLife, Inc. (NYSE: CRY), a leading cardiac and vascular surgery company focused on aortic disease, announced today that members of management will host one-on-one meetings at the upcoming Canaccord Genuity MedTech, Diagnostics, and Digital Health & Services Forum on Thursday, November 18, 2021. Due to the format of this event no webcast will be available.

Yahoo | November 9, 2021

Wall Street Analysts Think CryoLife (CRY) Could Surge 51%: Read This Before Placing a Bet

The mean of analysts' price targets for CryoLife (CRY) points to a 50.8% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.

Yahoo | November 8, 2021

Read More 'CRY' Stories Here

CRY Price Returns

1-mo N/A
3-mo N/A
6-mo N/A
1-year N/A
3-year -21.92%
5-year -36.03%
2023 N/A
2022 0.00%
2021 -13.81%
2020 -12.85%
2019 -4.55%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!